ONMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Onemednet Corp (ONMD) does not present a strong buy opportunity at this time for a beginner investor with a long-term strategy. While the company has shown significant financial improvement and reduced liabilities, its technical indicators and lack of strong trading signals do not support immediate entry. The stock's pre-market movement is minimal, and there are no significant positive catalysts or strong upward momentum to justify a buy decision now.
The MACD is slightly positive but contracting, RSI is neutral at 41.695, and moving averages are converging, indicating no clear trend. Key support is at 0.77, and resistance is at 1.048, suggesting limited upside potential in the short term.
million to $(3.
million. Revenue growth in 2025/Q4 was up 3326.92% YoY, indicating operational capability.
Despite revenue growth, the company remains unprofitable with a net income of -$3.1 million and a declining EPS (-0.06, down 25% YoY). Gross margin also dropped significantly to 18.52%, down 118.52% YoY, which raises concerns about profitability.
In Q4 2025, revenue increased significantly to $891,000 (up 3326.92% YoY), net income improved to -$3.1 million (up 30.79% YoY), but EPS dropped to -0.06 (down 25% YoY), and gross margin declined to 18.52% (down 118.52% YoY).
No analyst rating or price target data available.
